Skip to content

PsyIMPACT advisory committee

Professor G. Terence Wilson - Chair of PsyIMPACT Committee

Professor of Psychology at Rutgers University, USA and a member of the Graduate School of Applied and Professional Psychology. Throughout his career, Professor Wilson has focused on applying social learning to the treatment of clinical problems and the treatment of eating and weight disorders has been a major focus of his research. He is also the Editor-in-Chief of Behaviour Research and Therapy, the leading international journal on cognitive behaviour therapy.

Professor Wilson has received numerous awards throughout his career, most recently the Lifetime Achievement Award from the Academy of Eating Disorders (2013) and is the 2014 recipient of the Distinguished Scientific Award for the Application of Psychology from the American Psychological Association.

Professor Christopher Fairburn (ex officio)

Professor Fairburn is a Wellcome Trust Principal Research Fellow and Professor of Psychiatry at the University of Oxford. He has two main research interests; the nature and treatment of eating disorders, and the development, evaluation and dissemination of psychological treatments.  He has an international reputation in both fields.  Professor Fairburn is a Fellow of the Academy of Medical Sciences and has twice been a Fellow at Stanford’s Center for Advanced Study in the Behavioral Sciences.  Until recently, he was a Governor of the Wellcome Trust.

Chris is also a Trustee at MQ. 

Professor Paul Fletcher

Paul Fletcher is the Bernard Wolfe Professor of Health Neuroscience at the University of Cambridge. He is an internationally recognised leader in cognitive neuroscience and functional neuroimaging of psychiatric and other behavioural disorders. His work is strongly interdisciplinary and distinctive for its depth and sophistication in the cognitive analysis of symptom formation. Professor Fletcher has been able to translate cognitive neuroscience to metabolic medicine, as well as psychiatry, thus pioneering the new field of health neuroscience and contributing to a deeper, neuroscientific understanding of the maladaptive behaviours that often contribute to risk for somatic disorders.

He is a Fellow of the Academy of Medical Sciences and of the Royal College of Psychiatrists. He has been a Wellcome Trust Senior Research Fellow in Clinical science since 2002. 

Professor Ilina Singh

Professor of Neuroscience and Society at the University of Oxford and Professor of Science, Ethics & Society at King’s College London. Professor Singh’s work examines the psychosocial and ethical implications of advances in biomedicine and neuroscience for young people and families. She is a principal investigator of the project Voices On Identity, Childhood, Ethics and Stimulants: Children join the debate, a Wellcome Trust-funded research project that sheds fresh light on children’s experiences with ADHD diagnosis and stimulant drug treatments.

Professor Singh is Co-Editor of the journal BioSocieties, and is on the Editorial Board of The American Journal of Bioethics-Neuroscience. In 2013, she was elected a Fellow of the Hastings Centre, the oldest bioethics institution in the world.

Professor Edward Watkins

Professor of Experimental and Applied Clinical Psychology and Director of Research for Professional Doctorates at the University of Exeter. Professor Watkins currently works as a researcher, teacher and clinical practitioner within the Mood Disorders Centre at the University of Exeter and where he is also the Director of the Study of Maladaptive to Adaptive Repetitive Thought (SMART) lab. Professor Watkins currently serves as an expert member of the NICE Guidelines for Depression in Adults from 2015-2017.

In 2004, Professor Watkins was awarded the British Psychological Society's May Davidson Award. This award is for “a clinical psychologist who has made an outstanding contribution to the development of clinical psychology within the first 10 years of his/her work as a qualified clinical psychologist. The contribution may be through clinical research or other professional work. It should be innovative and of an order sufficient to become widely recognised as an important development in British clinical psychology".

Subscribe to our newsletter. Get the latest news on mental health.

© 2019 © MQ: Transforming mental health 2016 | Registered charity in England / Wales: 1139916 & Scotland: SC046075 | Company number: 7406055